His research carrier started in the year 2004 as a Research Associate/Study Director-Toxicology, R&D Center, The Himalaya Herbal Health Care, Bangalore. He underwent extensive training to conduct toxicity studies according to Good Laboratory Practice (GLP) at R&D Centre, The Himalaya Herbal Health Care, Bangaluru.
His carrier started in JSS as a Lecturer in the year 2007. Since then besides his teaching responsibilities he has interacted with many Pharmaceutical Industries and successfully completed more than 45 research projects worth around Rs. 80.0 Lakhs.
His arears of research interest include, Computer Aided Drug Discovery, Metabolic disorders-Diabetes Mellitus, Herbal drug research and Preclinical drug development. Currently, 6 Ph.D., Scholars are working under him guidance and He has guided more than 25 M. Pharm., students till date. He has published 45 research papers, a Book chapter and successfully filed an Indian patent. He is a reviewer for many National and International Journals.
He has received “Summer Research Fellowship-2014” from Science Academies, Govt. of India, for research training in Molecular biology at Institute of Life Sciences, Bhubaneshwar, Orissa, for 2 months with a stipend of Rs. 8000 per month. He has delivered 15 invited Speeches at various National Conferences and 3 speeches at International Conferences in USA and Malaysia. He received travel grants of Rs. 1,00,000/- (ICMR, New Delhi), Rs. 30,000/- (Tamilnadu State Council for Science and Technology, Chennai) and Rs. 25,000/ (CICS, Chennai) for attending these conferences.
He has received recently the following research grants from various funding agencies;
|
|
Title
|
Role
|
Amount (Rs)
|
Agency and Sanction date
|
-
|
Adipocyte specific delivery of oral thiazolidinedione nanoparticles functionalized with RGD and P3 peptides to reduce side effects and improve efficacy DST/NM/NB/2018/227
|
Principal Investigator
|
40.00 lakhs
|
DST, Nanomission, New Delhi
|
-
|
Death receptor-5 targeted lipid nanoparticles of γ-secretase inhibitor for simultaneous targeting of breast cancer cells and cancer stem cells BT/PR24607/NER/95/772/2017
|
Principal Investigator
|
56.66 lakhs
|
DBT, NEW Delhi
DBT-TWINING Project
Feb, 2018
|
-
|
Neuroprotection by nanoallosteric potentiators of M1 muscarinic acetylcholine receptors for reversal learning management in Alzheimer’s disease”
|
Principal Investigator
|
72.20 lakhs
|
DBT-Nano biotechnology, New Delhi
27-3-2015
|
As a Principal Investigator He is currently carrying out DBT sponsored Major Research Project entitled “. As a co-investigator He has successfully completed UGC sponsored Major Research Project entitled “Design synthesis and evaluation of some novel dipeptidyl peptidase IV inhibitors as antidiabetic agents” (Total grant amount-Rs. 10,86,800/-). Death receptor-5 targeted lipid nanoparticles of γ-secretase inhibitor for simultaneous targeting of breast cancer cells and cancer stem cells. [BT/PR24607/NER/95/772/2017]” Amount-Rs. 56.66 lakhs